Complement-Based Drug Development Summit leaderboard
  • Monday, August 31, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 397

Author

Pharma Journalist 9027 posts 0 comments

Asher Biotherapeutics Contracts ProBioGen to Develop and Manufacture Their Lead Candidate

Apr 27, 2021
ProBioGen AG announced that Asher Biotherapeutics, Inc., has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at…
Read More...

Mirum Pharmaceuticals Receives Notice of Allowance for Methods of Use Patent for Maralixibat in…

Apr 27, 2021
Mirum Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application No. 16/994,368. The…
Read More...

Sanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands

Apr 27, 2021
Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna´s COVID-19 vaccine, supporting the COVID-19 pandemic and vaccine supply needs.…
Read More...

Selumetinib recommended for approval in the EU by CHMP as the first medicine for paediatric patients…

Apr 27, 2021
AstraZeneca and MSD’s selumetinib has been recommended for conditional marketing authorisation in the European Union (EU) for the treatment of symptomatic, inoperable plexiform…
Read More...

Pieris Pharmaceuticals and Boston Pharmaceuticals Enter into an Exclusive Worldwide Product License…

Apr 26, 2021
Pieris Pharmaceuticals, Inc. and Boston Pharmaceuticals announced that the companies have entered into an exclusive product license agreement to develop PRS-342, a 4-1BB/GPC3…
Read More...

CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and…

Apr 26, 2021
CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced it has established a multi-year…
Read More...

Exclusive interview with Director Primary Packaging & Process Development, Boehringer Ingelheim…

Apr 26, 2021
SMi Reports: SMi Group are delighted to announce Christian Dechant, Director Primary Packaging & Process Development, Boehringer Ingelheim will be speaking at the Injectable Drug…
Read More...

Samsung Biologics and TG Therapeutics Expand Collaboration for the Large Scale Manufacture of…

Apr 26, 2021
Samsung Biologics and TG Therapeutics announced an expansion of a large-scale contract manufacturing deal for the supply of TG Therapeutics' ublituximab, an investigational anti-CD20…
Read More...

Registration Opens for SMi’s Aseptic Processing Conference 2021

Apr 23, 2021
SMi reports: Registration is now open for SMi’s Aseptic Processing Conference, which will convene in London on 20th and 21st September 2021. SMi Group are proud to announce the…
Read More...

Zenith Epigenetics Announces Clinical Collaboration with Astellas

Apr 22, 2021
Zenith Epigenetics Ltd. a clinical stage biotechnology company focused on the development of novel epigenetic combination therapies for the treatment of cancers, announces it has…
Read More...
Prev Next
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • FDA Approves Tivicay PD for Infants With HIV
  • FDA Grants Rare Pediatric Disease Designation to ReviR’s RTX-117
  • FDA Approves Ziihera Combinations for HER2-Positive GEA
  • FDA Approves RASONQUE for Metastatic Pancreatic Cancer
  • REGENXBIO Delays RGX-121 Filing After Spine MRI Findings

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.